1. The Synergistic and Opposing Roles of ω-Fatty Acid Hydroxylase (CYP4A11) and ω-1 Fatty Acid Hydroxylase (CYP2E1) in Chronic Liver Disease
   Hardwick James P et al, 2024, Genome Biology & Molecular Genetics CrossRef
2. Calpain as a Therapeutic Target for Hypoxic-Ischemic Encephalopathy
   Ruiyang Zhao et al, 2024, Molecular Neurobiology CrossRef
3. Identification and analysis of immunogenicity and immunotherapy efficacy by fatty acid genes: a novel prognostic features of lumbar disc herniation and Mendelian randomization analysis
   Qisong Shang et al, 2024, International Journal of Neuroscience CrossRef
4. Discovery of a selective cytochrome P450 4A inhibitor for the treatment of metabolic dysfunction‐associated fatty liver disease
   Minji Lee et al, 2024, Clinical and Translational Medicine CrossRef
5. Possible Hepatoprotective Effect of Tocotrienol-Rich Fraction Vitamin E in Non-alcoholic Fatty Liver Disease in Obese Children and Adolescents
   Farah D.R. Al-Baiaty et al, 2021, Frontiers in Pediatrics CrossRef
6. Elemental evaluation, nutritional analysis, GC-MS analysis and ameliorative effects of Artocarpus communis J.R.Forst. & G.Forst. seeds’ phytoconstituents on metabolic syndrome via in silico approach
   Akingbolabo Daniel Ogunlakin et al, 2023, Journal of Biomolecular Structure and Dynamics CrossRef
7. Metabolic dysfunction-associated steatotic liver disease-induced changes in the antioxidant system: a review
   Gabriela Svobodová et al, 2024, Archives of Toxicology CrossRef
8. The influence of the model pesticides parathion and paraoxon on human cytochrome P450 and associated oxygenases in HepaRG cells
   Gabriele Horn et al, 2024, Clinical Toxicology CrossRef
9. Integrated Proteomics and Bioinformatics to Identify Potential Prognostic Biomarkers in Hepatocellular Carcinoma
   Qifan Zhang et al, 2021, Cancer Management and Research CrossRef
10. Protective Effects of Tiaoganquzhi Decoction in Treating inflammatory Injury of Nonalcoholic Fatty liver Disease by Promoting CGI-58 and Inhibiting Expression of NLRP3 Inflammasome
    Huicun Zhang et al, 2022, Frontiers in Pharmacology CrossRef
11. Shining a Light on Inflammation as a Critical Modulator of Drug Metabolism
    Edward T. Morgan, 2024, Drug Metabolism and Disposition CrossRef
12. Immunometabolic factors contributing to obesity-linked hepatocellular carcinoma
    May G. Akl et al, 2023, Frontiers in Cell and Developmental Biology CrossRef
13. Artocarpus Communis Seed Regulates P53, IRS, HsD17β2, FTO, and CYP11a Genes in Polycystic Ovarian Syndrome Rats
    Akingbolabo Daniel Ogunlakin et al, 2024, OBM Genetics CrossRef
14. Concentration‐dependent effects of the nerve agents cyclosarin and VX on cytochrome P450 in a HepaRG cell‐based liver model
    Gabriele Horn et al, 2024, Journal of Applied Toxicology CrossRef
15. Differential expression of Cytochrome P450 1A2 in simple fatty liver and steatohepatitis
    Azusa Kawashima et al, 2023, Fundamental Toxicological Sciences CrossRef